MSK brings OncoKB tumor-genetics expertise to OpenEvidence, used by 85% of its oncologists

saranormous · x · 2026-10-22

Memorial Sloan Kettering Cancer Center and OpenEvidence announced that OncoKB — MSK's expert interpretation of tumor genetics — is now built directly into OpenEvidence, putting MSK-level precision oncology guidance in the hands of oncologists across the US.

Over 85% of MSK's oncologists already use OpenEvidence daily. Dr. Anaeze Offodile framed the move as part of MSK's mission to "end cancer for life." It's a landmark case of top-tier clinical knowledge being scaled through an AI tool to influence real medical decisions.

Original post →

More from Apps

• YC's Design Review: Magic Patterns demos MagicOS canvas and dissects why startup sites feel 'vibe coded' — ycombinator · 2026-10-22
• Atypica tests your ad creatives against 1M AI personas before you spend a dollar — manishkhosiya · 2026-10-22
• One prompt, 10 verified remote jobs in 10 minutes: a Dola agent job-hunt walkthrough — SucceededMind · 2026-10-22
• You're using Claude like Google search: Projects, Artifacts, scheduled tasks most users never touch — hey_abusiddik · 2026-10-22
• YC-backed Kiwi AI launches as a data engineer for GTM agents — ycombinator · 2026-10-22
• Lift Hundreds of 2D Photos Into a Flyable 3D "Geospatial Memory Palace" — bilawalsidhu · 2026-10-22

Apps channel →